News and Updates

Researchers have launched a first-in-human trial using laser-activated therapy to target pancreatic cancer. Discover how this innovative technique works.

Can AI safely diagnose patients? Explore why rigorous clinical trials are a non-negotiable step for the future of conversational medical AI.

The PDUFA reauthorization is a critical opportunity for the FDA to modernize clinical trials. Explore the potential for policy reform and patient impact.

Acclinate is evolving its clinical trial diversity strategy by leveraging advanced data analytics to ensure more equitable and representative research.

Learn why early clinical trial strategy is essential for reducing delays, improving recruitment, and ensuring regulatory success in drug development.

AbelZeta secures FDA clearance for a Phase 1b/2 trial of C-CAR168, a CAR-T cell therapy targeting progressive multiple sclerosis. Learn about the implications.

Phio Pharmaceuticals advances PH-762 for cutaneous squamous cell carcinoma following a key FDA filing to support the next stage of clinical development.

Pasithea Therapeutics shares early clinical data from its latest drug pipeline. Explore the potential implications for neurological and psychiatric care.

Discover how integrated EDC platforms are revolutionizing clinical data management, enhancing regulatory compliance, and accelerating trial timelines.

Clinical trials are reaching unprecedented levels of complexity. Explore how precision medicine and digital tech are reshaping the future of drug development.